Vimarsana
Biggest News Aggregation in the World

Page 4 - Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

Innovis Asset Management LLC Purchases Shares of 80,773 Immunic, Inc. (NASDAQ:IMUX) - Vimarsana News

Innovis Asset Management LLC Purchases Shares of 80,773 Immunic, Inc. (NASDAQ:IMUX)

Innovis Asset Management LLC purchased a new stake in Immunic, Inc. (NASDAQ:IMUX – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 80,773 shares of the company’s stock, valued at approximately $120,000. Innovis Asset Management LLC owned 0.18% […]

Immunic (NASDAQ:IMUX) Rating Reiterated by Wedbush - Vimarsana News

Immunic (NASDAQ:IMUX) Rating Reiterated by Wedbush

Wedbush restated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com started coverage on Immunic in a research note on Thursday, May 18th. They issued a sell rating on the stock. […]

Source: wkrb13.com
Immunic (NASDAQ:IMUX) Receives Outperform Rating from Wedbush - Vimarsana News

Immunic (NASDAQ:IMUX) Receives Outperform Rating from Wedbush

Wedbush reaffirmed their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday morning, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com initiated coverage on Immunic in a research report on Thursday, May 18th. They set a sell rating on the […]

Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update

– Preclinical Data Published in the Journal of Medicinal Chemistry Identifies Vidofludimus Calcium as a Potent Nurr1 Activator, Reinforcing Neuroprotective...

Immunic to Participate in Investor and Scientific Conferences in August - Vimarsana News

Immunic to Participate in Investor and Scientific Conferences in August

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...